Skip to main content

Chloraseptic Total Sore Throat+Cough Lozenges Side Effects

Generic name: benzocaine / dextromethorphan / menthol

Note: This document contains side effect information about benzocaine / dextromethorphan / menthol. Some dosage forms listed on this page may not apply to the brand name Chloraseptic Total Sore Throat+Cough Lozenges.

Applies to benzocaine/dextromethorphan/menthol: mucous membrane lozenge.



Frequency not reported: Angioedema


Rare (less than 0.1%): Fixed-drug eruptions

Frequency not reported: Angioedema[Ref]



Frequency not reported: Contact dermatitis, urticaria


Frequency not reported: Pruritus, rash, urticaria[Ref]



Frequency not reported: Burning, stinging


Frequency not reported: Application site redness/irritation[Ref]



Frequency not reported: Abdominal pain, diarrhea, gastrointestinal disturbance, nausea, upset stomach, vomiting[Ref]



Frequency not reported: Abuse, excitation, insomnia, mental confusion[Ref]

Nervous system


Frequency not reported: Convulsions, dizziness, drowsiness[Ref]



Postmarketing reports: Methemoglobinemia[Ref]



Frequency not reported: Respiratory depression[Ref]



Frequency not reported: Edema[Ref]

More about Chloraseptic Total Sore Throat+Cough Lozenges (benzocaine / dextromethorphan / menthol)

Related treatment guides


1. Stubb S, Reitamo S "Fixed-drug eruption due to dextromethorphan ." Arch Dermatol 126 (1990): 970-1

2. Hall RC, Beresford TP, Stickney SK, Nasdahl CS, Coleman JH "Psychiatric reactions produced by respiratory drugs." Psychosomatics 26 (1985): 605-8,616-7

3. Helfer J, Kim OM "Psychoactive abuse potential of Robitussin-DM." Am J Psychiatry 147 (1990): 672-3

4. Murray S, Brewerton T "Abuse of over-the-counter dextromethorphan by teenagers." South Med J 86 (1993): 1151-3

5. Wolfe TR, Caravati EM "Massive dextromethorphan ingestion and abuse." Am J Emerg Med 13 (1995): 174-6

6. Polles A, Griffith JL "Dextromethorphan-induced mania." Psychosomatics 37 (1996): 71-4

7. Bostwick JM "Dextromethorphan-induced manic symptoms in a bipolar patient on lithium." Psychosomatics 37 (1996): 571-2

8. Knowles SR, Weber E "Dextromethorphan anaphylaxis." J Allerg Clin Immunol 102 (1998): 316-7

9. "Product Information. Stopain (menthol topical)." DRJ Group Inc (2003):

10. "Product Information. Cold and Hot (menthol topical)." Major Pharmaceuticals Inc

11. "Product Information. BENGAY Pain Relieving (menthol topical)." Pfizer U.S. Pharmaceuticals Group (2004):

12. "Product Information. Solarcaine Plus Aloe (benzocaine topical)." Schering-Plough Healthcare Products (2005):

13. "Product Information. Americaine Hemorrhoidal (benzocaine topical)." Novartis Consumer Health (2005):

14. "Product Information. Dermoplast (benzocaine topical)." MedTech Inc (2005):

15. "Product Information. Outgro Pain Relief (benzocaine topical)." MedTech Inc (2005):

16. "Product Information. Cepacol Lozenges (cetylpyridinium topical)." GlaxoSmithKline Inc (2005):

17. "Product Information. Chloraseptic (benzocaine topical)." Procter and Gamble Pharmaceuticals (2005):

18. "Product Information. Vagisil Feminine Cream (benzocaine topical)." Combe Inc (2005):

19. "Product Information. Lanacane (benzocaine topical)." Combe Inc (2005):

20. "Product Information. Hurricaine (benzocaine topical)." Beutlich (2005):

21. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

22. Throm MJ, Stevens MD, Hansen C "Benzocaine-induced methemoglobinemia in two patients: interdisciplinary collaboration, management, and near misses." Pharmacotherapy 27 (2007): 1206-14

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.